SAFE BULKERS, INC.
SAFE BULKERS, INC. (SB) Stock News
The latest SB headlines and market coverage — 7 recent stories, updated throughout the day.
- GlobeNewswire Inc.·
SBM Offshore intends to divest minority interest in FSO Chalchi
SBM Offshore has entered into a shareholders' agreement with Nippon Yusen Kabushiki Kaisha (NYK) to divest a 45% ownership interest in special purpose companies related to the FSO Chalchi lease and operation. SBM Offshore will retain 55% majority ownership. The FSO Chalchi, a Suezmax-type vessel under construction, will operate under 20-year contracts with Woodside Energy at the Trion field offshore Mexico.
- Benzinga·
NASB Financial, Inc. Declares Cash Dividends on Common Stock
NASB Financial, Inc. (OTCQX: NASB) announced that its Board of Directors declared a quarterly cash dividend of $0.35 per share, payable on June 26, 2026, to stockholders of record on June 12, 2026.
- Benzinga·
Why Sunshine Biopharma (SBFM) Stock Dropped After Hours Today
Sunshine Biopharma (NASDAQ:SBFM) shares fell 5.17% to $0.30 in after-hours trading following the announcement of a one-for-ten reverse stock split effective June 1, 2026. The reverse split was undertaken to regain compliance with Nasdaq's minimum bid price requirement. The stock has declined 77.99% over the past 12 months and currently has a market capitalization of approximately $5.18 million.
- GlobeNewswire Inc.·
SBC Medical and BLEZ ASIA Celebrate Opening of New Aesthetic Dermatology Section at BLEZ CLINIC in Bangkok
SBC Medical Group Holdings (Nasdaq: SBC) announced the opening of a new aesthetic dermatology section at BLEZ CLINIC in Bangkok's Asok district through its consulting partnership with BLEZ ASIA Co., Ltd. The section will offer pico laser treatments targeting pigmentation and spot removal, with services launching in June 2026. The expansion targets Japanese expatriates in Thailand and aims to establish a foundation for broader growth across the Thai market and ASEAN region.
- GlobeNewswire Inc.·Neutral
Ichnos Glenmark Innovation (IGI) Announces New Development Candidate, ISB 2301, a First-in-Class Multispecific Immune Cells Activator Targeting Solid Tumors
Ichnos Glenmark Innovation (IGI) announced ISB 2301, a first-in-class multispecific antibody that targets three tumor-associated antigens and activates both T cells and NK cells for solid tumor treatment. The candidate, developed using IGI's proprietary BEAT® platform, demonstrated favorable safety profiles in preclinical studies and is expected to advance toward clinical trials with an IND submission planned by end of 2026.
- Benzinga·
Bank First Corporation Signs Agreement to Acquire PSB Holdings, Inc.
Bank First Corporation (NASDAQ: BFC) has agreed to acquire PSB Holdings, Inc., parent company of Peoples State Bank, in an all-stock transaction valued at approximately $202.9 million. The merger will combine two community banks to create an institution with over $7.6 billion in assets, expanding Bank First's presence into North Central Wisconsin and the greater Milwaukee area. The transaction is expected to close in Q4 2026, subject to regulatory and shareholder approvals.
- Seeking Alpha·Bullish
SB Financial Group Non-GAAP EPS of $0.63 beats by $0.03, revenue of $17.42M beats by $4.82M